Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 3
2020 2
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

6 results
Results by year
Filters applied: . Clear all
Page 1
Association of the Metabolic Score Using Baseline FDG-PET/CT and dNLR with Immunotherapy Outcomes in Advanced NSCLC Patients Treated with First-Line Pembrolizumab.
Seban RD, Assié JB, Giroux-Leprieur E, Massiani MA, Soussan M, Bonardel G, Chouaid C, Playe M, Goldfarb L, Duchemann B, Mezquita L, Girard N, Champion L. Seban RD, et al. Among authors: goldfarb l. Cancers (Basel). 2020 Aug 10;12(8):2234. doi: 10.3390/cancers12082234. Cancers (Basel). 2020. PMID: 32785166 Free PMC article.
Sub-cutaneous Fat Mass measured on multislice computed tomography of pretreatment PET/CT is a prognostic factor of stage IV non-small cell lung cancer treated by nivolumab.
Popinat G, Cousse S, Goldfarb L, Becker S, Gardin I, Salaün M, Thureau S, Vera P, Guisier F, Decazes P. Popinat G, et al. Among authors: goldfarb l. Oncoimmunology. 2019 Mar 6;8(5):e1580128. doi: 10.1080/2162402X.2019.1580128. eCollection 2019. Oncoimmunology. 2019. PMID: 31069139 Free PMC article.